Comparing two pacing methods to prevent heart dysfunction
Official title: Left Septal Pacing or Left Bundle Branch Pacing to Avoid Left Ventricle Systolic Dysfunction. A Multicenter Randomized Trial From the STAY Investigators
Run by Parc de Salut Mar · NCT06707662 · Data updated 2026-11-12
This study is testing if two new pacing methods for heart patients can better protect heart function compared to the traditional method.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Parc de Salut Mar Academic / other |
| Locations | 1 site (Barcelona) |
| Status | Recruiting |
| Started | January 1, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | February 11, 2025 |
| Trial ID | NCT06707662 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with preserved or mildly deteriorated left ventricular ejection fraction and a high burden of expected ventricular pacing.
✕Probably not a fit
Patients with severe left ventricular dysfunction, those requiring implantable cardioverter defibrillators, or those with recent significant cardiac events may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to compare the effectiveness of left septal pacing (LVSP) and left bundle branch pacing (LBBP) against conventional right ventricular apical pacing (RVAP) in patients with high-degree atrioventricular block. The study will involve a multi-center, prospective, randomized design, where participants will be assigned to one of the pacing methods during pacemaker implantation. The primary goal is to determine whether LVSP can better preserve left ventricular function compared to LBBP and RVAP in patients with preserved or mildly deteriorated left ventricular ejection fraction. Outcomes will be assessed over a 12-month period following the procedure.
Why it matters
Potential benefit: If successful, this study could lead to improved heart function and reduced heart failure admissions for patients requiring pacemakers.
How similar studies have gone: Previous studies have shown success with conduction system pacing approaches, indicating potential for this trial's methodology.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age of 18 years or more. 2. Preserved or mild deteriorated LVEF (Simpson \>40%) assessed by a recent (\<1 month before implantation) transthoracic echocardiography. 3. Indication for pacing based on the presence of a high degree AVB, and consequently with an anticipated high burden of ventricular pacing (\>80%). 4. Life expectancy of more than 12 months and capability to understand the protocol, signing informed consent form, and complying with follow-up. Exclusion Criteria: 1. Patients with indication for implantable cardioverter defibrillator device. 2. Patients with indication for a CRT device, with LVEF \<40%. 3. Patients with previous severe LVD (Simpson LVEF \<30%) and a recovered LVEF. 4. History of myocardial infarction/revascularization or cardiac surgery within 6 months before randomization. 5. Pregnancy, active cancer treatment, or participation in another clinical trial with active treatment.
Where it's running
-
Hospital del Mar - IMIM
Barcelona, Spain Recruiting
Study contacts
- Study coordinator: Ermengol Valles, PhD
- Email: ermengolvalles@mac.com
- Phone: 0034666437038
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SPIKE FLOW endocardial pacing lead safety and performance study
This study tests whether the SPIKE FLOW temporary endocardial pacing lead is safe and effective in adults needing temporary pacing during heart-related conditions.
-
Micra AV2 leadless pacemaker to improve AV synchrony in AV block
This study will test whether the Micra AV2 leadless pacemaker improves AV synchrony and is safe for adults with high‑degree AV block who have normal sinus rhythm.
-
LivIQ leadless pacemaker system for ventricular pacing
This trial will test the LivIQ leadless pacemaker in adults who need ventricular pacing (VVI or VDD) to see if it is safe and maintains appropriate heart rhythm and AV timing.
-
Comparing two pacing methods after heart valve surgery
This study is testing whether a new way of pacing the heart after valve surgery can help patients feel better and have better heart function compared to a standard method.
-
Comparing His and Left Bundle Branch Pacing for Heart Failure
This study is testing whether a new way of pacing the heart can help people with heart failure feel better and stay out of the hospital compared to the usual treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.